Subscribe to Newsletter

Register now to stay tuned!
Company

Company

Next generation therapies will depend upon correction of pathological gene products within diseased cells by direct gene transfer, or by transplant of healthy cells.

These approaches have in common the need of transferring to cells of interest genetic material necessary to “heal” and change them into an healthy cell.
 
NuvoVec offers to the researchers of today and to the physicians of the near future the technology to do this in an efficient and controlled menner.
 
The mission of NuvoVec srl is to “create and launch in the market non-pathogenic vectors capable to introduce any gene or combination of genes in any cell type”